Spine, orthopedic implant company closes $3.35M in investment

Spinal Tech

Happe Spine, a company developing spine and orthopedic implants, closed $3.35 million in series A capital.

The funding came from investors within the spine industry and the Genesis Innovation Group, according to a Nov. 8 news release. Happe Spine plans to use the money to launch an implant for spinal fusions.

Happe Spine has a proprietary material platform, HydroxyApatite Porous Peek, for implants. The material's allograft-like qualities are designed to help improve clinical outcomes in interbody spinal fusions.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers